Equity Story

• HumanOptics develops, produces and sells high technology products for eye surgery, which enable the patients to retrieve the best possible visual function.
• The customizable intraocular lenses (most of them with additional functions) offer an ideal solution for a high number of eye surgeries, especially for cataracts, which is the most performed surgical eye procedure worldwide. An estimated growth potential of 6-8% per year is expected.
• Additional high growth potential for intraocular lenses (IOLs) as the first alternative to laser treatments in so called refractive surgery (correction of refractive errors) such as short- sightedness (Myopia) or far-sightedness (Hyperopia) or astigmatism.
• Excellent R&D know-how basis for innovative products (Diffractive IOLs, Add-on lenses, artificial iris) to further diversify revenues.
• Distribution network in over 40 countries on all 5 continents, disproportionately growth opportunities especially in Asia.